Zoetis, Inc.
(NYSE : ZTS)

( )
ZTS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. 0.67%201.931.9%$430.67m
TEVATeva Pharmaceutical Industries Ltd. -2.15%8.652.0%$79.63m
RDYDr. Reddy's Laboratories Ltd. -1.41%61.472.0%$5.70m
TXMDTherapeuticsMD, Inc. -2.86%0.3414.2%$2.59m
JAGXJaguar Health, Inc. -1.11%0.862.6%$2.07m
TAROTaro Pharmaceutical Industries Ltd. -0.63%47.506.6%$1.01m
ABEOAbeona Therapeutics, Inc. -2.07%0.252.5%$0.97m
COCPCocrystal Pharma, Inc. -3.09%0.550.0%$0.51m
LFVNLifeVantage Corp. -2.02%6.313.6%$0.28m
CPHIChina Pharma Holdings, Inc. -2.53%0.400.1%$0.11m

Company Profile

Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States & International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and livestock farmers. The company provides its services through five categories: anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.